https://www.als-mnd.org/support-for-pals-cals/research/us-fda-orphan-drug-designation/
US FDA Orphan Drug Designation
orphan drug designationus fda
https://www.regmednet.com/cell-therapy-weekly-orphan-drug-designation-for-brain-cancer-car-t-cell-therapy/
Cell Therapy Weekly: Orphan Drug Designation for CAR-T Therapy - RegMedNet
Jul 11, 2025 - Mustang Bio's CAR T-cell therapy MB-101 for astrocytoma and glioblastoma has received Orphan Drug Designation.
orphan drug designationcell therapyfor carweekly
https://www.sanofi.com/en/media-room/press-releases/2026/2026-03-02-06-00-00-3247008
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related...
Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Designation based on positive data from a phase 2 study of rilzabrutinib...
orphan drug designationpress releasein japan
https://elixirgentx.com/elixirgen-therapeutics-granted-fda-orphan-drug-designation-for-exg-34217-for-treatment-of-telomere-biology-disorders/
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere...
BALTIMORE, February 20, 2025 – Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the...
orphan drug designationtherapeuticsgrantedfdatreatment
https://en.cmicgroup.com/news-events/notice-regarding-designation-as-an-orphan-drug-and-supplemental-new-drug-application-for-sodium-phenylbutyrate-for-designated-intractable-disease-progressive-familial-intrahepatic-cholestasis-pfic/
Notice regarding Designation as an Orphan Drug and Supplemental New Drug Application for Sodium...
Oct 16, 2025 - Notice regarding Designation as an Orphan Drug and Supplemental New [...]
orphan drugnew application